Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Xencor, Inc.
Children's Oncology Group
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Loma Linda University
Wake Forest University Health Sciences